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Abstract
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Alopecia areata (AA) is a prevalent autoimmune disease with ten known susceptibility loci. Here
we perform the first meta-analysis in AA by combining data from two genome-wide association
studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases
and 7,543 controls. The strongest region of association is the MHC, where we fine-map 4
independent effects, all implicating HLA-DR as a key etiologic driver. Outside the MHC, we
identify two novel loci that exceed statistical significance, containing ACOXL/BCL2L11(BIM)
(2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/
ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions
demonstrates expression in relevant immune cells and the hair follicle. We integrate our results
with data from seven other autoimmune diseases and provide insight into the alignment of AA
within these disorders. Our findings uncover new molecular pathways disrupted in AA, including
autophagy/apoptosis, TGFß/Tregs and JAK kinase signaling, and support the causal role of
aberrant immune processes in AA.

Author Manuscript

Introduction
Alopecia areata (AA) is one of the most prevalent autoimmune diseases, with a lifetime risk
of 1.7%,1 and is the most common cause of hair loss in children. In AA, aberrant immune
destruction is targeted to the hair follicle resulting in non-scarring hair loss that typically
begins as patches, which can increase in size and coalesce and may progress to cover the
entire scalp (alopecia totalis, AT), and body as well (alopecia universalis, AU). Disease
prognosis is unpredictable and highly variable. Its etiologic basis has remained largely
undefined, creating barriers to the development of effective therapeutic strategies and an
enormous unmet medical need.2,3

Author Manuscript

Our first GWAS in AA identified associations in eight regions of the genome which were
subsequently confirmed in independent candidate gene studies.4-7 Associated loci outside
the HLA highlight particular immune response pathways and also implicate genes expressed
in the hair follicle. For example, several regions contain genes with Treg functions,
including IL2RA, IL2/IL21, CTLA4 and Eos, whereas ULBP3/ULBP6 implicate NKG2D
mediated cytotoxic T-cells. Within the hair follicle, expression of STX17 suggests a role for
end-organ autophagy, while PRDX5 implicates oxidative stress. A combined analysis of this
GWAS and a subsequent replication study led to the identification of IL13/IL4 and
KIAA0350/CLEC16A as new gene loci.5
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Here we perform a meta-analysis to expand our sample size and identify two new loci that
exceed our threshold for genome-wide significance and a third locus that is nominally
significant. We identify transcripts and/or protein for candidate genes at all three loci in
disease relevant tissues. We perform imputation and fine-mapping of the HLA identifying
four independent associations that implicate HLA-DRβ1. Finally, CPMA of our data with
published results from seven other autoimmune diseases identify molecular pathways shared
by AA and one or more other disorders.

Results

Author Manuscript

In this study, we have increased our cohort size and performed a combined analysis of two
GWAS using Illumina Human660W- and Omni1-Quad BeadChips, analyzing a total of
2,489 cases and 5,287 controls ascertained in the US and Central Europe (Supplementary
Table 1). Association analyses are performed with logistic regression. In a meta-analysis of
these data, nine of the previously implicated regions exceeded statistical significance
(p<5×10−8), with STX17 achieving nominal significance (rs10124366; p=1.09×10−5) (Figure
1 and Supplementary Data 1).

Author Manuscript

First, in order to resolve the MHC association signal (p = 4.91×10−58 for the best SNP,
rs9275516), we used a published imputation and analysis protocol to perform fine-mapping
(Supplementary Data 2).8 Conditional analysis revealed four independent variants located at
the classical HLA-DRA and HLA-DRB1 genes. The most significant variant was amino acid
position 37 in HLA-DRβ1 (omnibus p-value = 4.99×10−73). Of the five possible amino acids
at this position, Leu (OR=1.56), Tyr (OR=1.54) and Phe (OR=1.19) conferred a higher risk
of AA whereas the other residues conferred lower risk (OR for Asn=0.42; OR for Ser=0.74).
Adjusting for the effects of HLA-DRβ1 amino acid position 37, we found an independent
association due to an intronic SNP of HLA-DRA, rs9268657 (OR=0.63, p-value = 4.48E−41).
Functional annotation of this SNP and its close proxies (R2>0.9) reveal that they influence
expression levels of HLA-DRB1.9 Adjusting for both HLA-DRβ1 amino acid position 37
and rs9268657, we identified another independent association for the classical allele HLADRB1*04:01 (OR=1.64, p-value=1.76×10−12), confirming previous associations in
candidate gene studies.10,11 Lastly, adjusting for HLA-DRβ1 amino acid position 37,
rs9268657 and HLA-DRB1*04:01, amino acid position 13 in HLA-DRβ1 was also
significant (p-value=4.57×10−16). Of the 6 possible alleles at this position, three increased
risk (Tyr, OR=1.41; Ser, OR=1.35; Phe, OR=1.09), two are protective (His, OR=0.57; Gly,
OR=0.50) and one demonstrated no effect (Arg, OR=0.98) (Supplementary Table 2).
Further rounds of conditional analyses yielded no additional significant results
(p>2.11×10−6).

Author Manuscript

Collectively, these four independent associations in the MHC implicate HLA-DR as the
primary risk factor in AA, presumably through antigen presentation, similar to other
immune-mediated diseases.12 For example, HLA-DRβ1 amino acid positions 13 and 37
contribute to P4 and P9 peptide-binding pockets respectively; the disease associations of
HLA-DRB1*04:01 are thought to be driven by the shared epitope (amino acid residues
70-74),12 which also occur within the peptide binding cleft (Figure 2). Polymorphic residues
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within peptide binding pockets of HLA-DR influence binding affinities of peptides and thus
may shape the repertoire of autoantigens capable of triggering or perpetuating disease.
Next, we performed replication of SNPs in functionally relevant loci that achieved
suggestive evidence for association in the meta-analysis (5×10−8>p>1×10−5), utilizing an
independent cohort of Central European ancestry. The Immunochip was used to genotype
318 cases and 1,688 controls and a Sequenom assay was used to genotype 85 SNPs not
included on the Immunochip in a cohort of 764 cases and 568 controls. This analysis
identified statistically significant associations in two novel genomic regions: chromosome
2q13 containing ACOXL and BCL2L11 (rs3789129, p=1.51×10−8, ORA=1.3) and
chromosome 11q13.5 containing C11orf30 and LRCC32 (rs2155219, p=1.25×10−8,
ORT=1.2) (Table 1 and Supplementary Data 3).

Author Manuscript
Author Manuscript

The association signal at chromosome 2q13 is located within an intron of ACOXL, and the
region of association extends to include BCL2L11 (Figure 3). This region has been
implicated in GWAS for two other autoimmune diseases: IgA Nephropathy and primary
sclerosing cholangitis.13 ACOXL belongs to the acyl-CoA oxidase gene family. While other
family members play well-studied roles in peroxisomal beta-oxidation, very little is known
about the function of this gene. BCL2-like 11, also known as BIM, is a member of the
BCL-2 protein family and contains a Bcl-2 homology domain 3 (BH3) that interacts with
other members to act as a pro-apoptotic factor. BIM has been widely studied in the context
of apoptosis of immune cells, and has also been implicated in apoptosis of melanocytes.14
More recently data has emerged that implicates BIM in the destruction of some end-organs
in autoimmune diseases, such as pancreatic beta cells in type 1 diabetes (T1D).15
Furthermore, BIM has also been shown to regulate autophagy,16 adding to growing evidence
for the importance of this process in AA as recently shown by functional studies of
STX17.17,18

Author Manuscript

BIM is widely expressed in multiple cell types, including immune-related, epithelial and
hair follicle cells.19 We first performed RT-PCR analysis of BIM expression in immune cells
and scalp hair follicles. We detected BIM transcript in whole PMBCs, including T, NK, B,
cells and monocytes (Figure 4A). In plucked human scalp hair follicles we observed
expression of an alternative splice isoform, BIM-S, the most pro-apoptotic variant (Figure
4A).20,21 To characterize protein localization within hair follicles, we performed
immunofluorescence staining on both human and mouse hair follicles. In the human hair
follicle, BIM is highly expressed in the bulb of the hair follicle, especially within the matrix
cells, in a pattern strikingly restricted to early catagen but not anagen or telogen (Figure 4B).
The hair bulb matrix is the principal location of differentiated, pigment producing
melanocytes, which are postulated to undergo apoptosis during catagen.22 In mouse hair
follicles, BIM localized to the apoptosing strand and lower portion of the catagen hair
follicle, consistent with its expression in human hairs. Remarkably, BIM expression was
restricted to catagen hair follicles, where immunofluorescence staining performed on anagen
or telogen hairs produced no signal (Figure 4C, upper panel). Finally, to investigate a
possible role of BIM in AA pathogenesis, we utilized a mouse model that recapitulates
genetic and molecular profiles of human AA.23 C3H/HeJ spontaneously develops AA and
we performed immunofluorescence staining on affected and unaffected skin. We observed a
Nat Commun. Author manuscript; available in PMC 2015 July 22.
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striking and widespread increase in BIM expression throughout affected skin and hair
follicles, that was not restricted to catagen hair follicles and appeared further upregulated in
lesional skin (Figure 4C, lower panel). The regression stage of a normal cycling hair follicle,
catagen, is characterized by apoptosis and cell death. We postulate that dysregulation of
BIM in hair matrix keratinocytes and/or hair follicle melanocytes contributes to the early
entry into dystrophic catagen in AA hair follicles in active disease.

Author Manuscript

The second novel region that exceeded statistical significance at chromosome 11q13.5
(rs2155219, P =1.25×10−8) contains three gene transcripts, including C11orf30, GUCY2E,
and GARP (LRRC32). GWAS have implicated this region in several autoimmune and
inflammatory diseases (www.genome.gov/gwastudies). GARP is expressed on activated
Tregs and binds and augments TGF beta bioavailability23-26, functioning to induce FOXP3
expression and Treg differentiation. Expression of GARP on activated human Treg cells
correlates with their increased suppressive activity and GARP knockdown reduces their
suppressive activity.24,27 Not surprisingly, we found that GARP is highly expressed in
whole PBMCs, consistent with previous reports. Unexpectedly, we also detected a strong
signal for GARP in plucked control scalp hair follicles, a site not previously described and
perhaps atypical for the expression of a Treg protein (Figure 4). This suggests a potential
role for GARP in hair biology and implicates significance of its disruption in AA at the site
of pathology for the phenotype.

Author Manuscript
Author Manuscript

A third novel region on chromosome 12q24.12 that achieved suggestive evidence for
association (p=1.3×10−7) is of interest because several genes harbored within the region
functionally align with other associated genes. This region has demonstrated associations to
multiple autoimmune diseases and contains 10 genes including SH2B adaptor protein 3
(SH2B3) and aldehyde dehydrogenase 2 family (ALDH2). SH2B3, also known as LNK, is a
key negative regulator of cytokine signaling via receptor tyrosine kinases and JAK
signaling. Two missense variants that confer increased cytokine production and enhanced
signaling have been reported in the literature (rs3184504 and rs72650673).28,29 We
genotyped these two functional polymorphisms in a sample of 96 chromosomes from AA
patients carrying the AA associated risk allele (rs653178*G) and found that 93
chromosomes also carried the rs3184504*T risk allele (f=.97). This increase in allele
frequency over what would be expected among a sample of European Americans (f=0.51 in
Exome Variant Server ESP6500) indicates that there is strong LD between the AA
associated risk variant and this functional polymorphism and suggests that R262W could be
contributing to AA pathogenesis. The rs72650673*A allele was not found in our sample,
consistent with its low allele frequency among European Americans (f=0.002 in Exome
Variant Server ESP6500). We found by RT-PCR analysis that LNK is highly expressed in
whole PBMCs, as well as T cells, natural killer, B cells, monocytes, but did not detect
expression in plucked scalp hair follicles (Figure 4). ALDH2 has been identified as a
citrullinated antigen in RA patients.30 This gene has been studied in the skin, with
expression localizing to epidermis, sebaceous glands and hair follicles, where it is
hypothesized to reduce the accumulation of oxidative stress-induced aldehydes.31
The strong association with HLA class II in AA, points towards the involvement of CD4+ T
cells in the pathogenesis. The importance of this T cell subset is supported by the presence
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of perifollicular CD4+ T cells in addition to intrabulbar CD8+ T cells in human AA. Finally,
we analyzed these data in the context of other autoimmune disease by performing a cross
phenotype meta-analysis using the 107 SNPs used in the original description of the analysis
and data from seven other autoimmune disease.32 We found 50 SNPs that had significance
at or near significance across two or more diseases, and clustering of these according to their
association with disease identified five groups (Figure 5 A,B). Protein-protein interaction
graphs of each SNP cluster demonstrate that for several of the groups, the proteins coded
from these regions interact either directly or via an intermediary to a significant degree
(Figure 5C). Integration of AA into the CPMA demonstrates mechanistic alignment with
celiac disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis and Crohn's disease,
with most of the overlap coming from the first cluster of genes.

Author Manuscript

Collectively, this meta-analysis for the first time resolves HLA associations and
demonstrates the pivotal etiological role of HLA-DR. Furthermore, the identification of
specific residues in HLA-DRβ1 that are overrepresented among AA patients will allow us to
better model peptide class II MHC interactions and thus predict autoantigens in AA.
Associations outside HLA provide new evidence for the importance of Treg maintenance
and immune response pathways in AA. Furthermore, autophagy and apoptosis are emerging
as processes of etiologic importance in AA. These insights will allow us to better understand
the molecular taxonomy of autoimmune diseases and the alignment of AA within this class
of disorders. Importantly, as GWAS help to resolve disease mechanisms and identify
pathogenic pathways perturbed in AA and autoimmunity in general, these approaches
advance the field towards precision medicine in autoimmunity.

Methods
Author Manuscript

Patient Population
All participating studies were reviewed and approved by the Institutional Review Boards
and ethics committees at Columbia University; MD Anderson Cancer Center; University of
Minnesota, Minneapolis; University of Colorado, Denver; University of California, San
Francisco; and the Universities of Bonn, Düsseldorf, Münster, Berlin, Hamburg, and
Munich, Germany; and Antwerp, Belgiumand were conducted in accordance with the
Declaration of Helsinki Principles. All study subjects provided written informed consent.

Author Manuscript

For the previously published GWAS and the ImmunoChip samples, cases were ascertained
through the National Alopecia Areata Registry (NAAR), which recruits patients in the
United States through five clinical sites and confirms diagnosis. Control data for these
samples were obtained from publically available data. There were two sources of control
data for the GWAS.4 First, a dataset was obtained from subjects enrolled in the New York
Cancer Project (NYCP)33 and genotyped as part of previous studies.34 Second, a dataset was
obtained from the CGEMS breast35 and prostate36 cancer studies (http://cgems.cancer.gov/
data/). The ImmunoChip control data was obtained from the NIDDK inflammatory bowel
disease (IBD) genetics consortium (http://medicine.yale.edu/intmed/ibdgc/index.aspx). The
cases and controls for the previously unreported GWAS were ascertained from outpatient
clinics, private dermatology practices and via AA self-support groups in Belgium and
Germany. Inclusion criteria followed published guidelines,37 and additionally included
Nat Commun. Author manuscript; available in PMC 2015 July 22.
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diagnosis by a trained and experienced clinician. European GWAS controls included
population-based controls established within the National Genome Research Network for
use as universal controls (PopGen38, KORA39), and the Heinz Nixdorf Recall (HNR)
Study40 and an additional population-based cohort from the HNR40 study. Sample counts by
ascertainment location and genotyping platform are summarized in Supplementary Table 1.
Genotyping

Author Manuscript

DNA was extracted from peripheral blood leukocytes by salting out with saturated NaCl
solution according to standard methods, or by using a Chemagic Magnetic Separation
Module I (Chemagen, Baesweiler, Germany) in accordance with the manufacturer's
instructions. Whole genome genotyping for the meta analayis was performed on either
Illumina HumanHap550 BeadChip or the Illumina Omni express, as detailed in
Supplementary Table 1. The replication cohort was genotyped with the Illumina
Immunochip. Additionally, SNPs selected for replication that are not present on the
Immunochip were genotyped on the MassArray system using a Sequenom Compact
MALDI-TOF device and iPLEX Gold reagents (Sequenom, San Diego, CA) in multiplex
reactions. Primer sequences and standard assay conditions are available upon request.
Standard quality control metrics were employed, removing data for SNPs and samples with
call rates less than 90. Additional genotyping was performed by standard PCR based
techniques.
Discovery QC and Imputation

Author Manuscript
Author Manuscript

Technical quality control was performed with quality control conducted on each dataset
separately using a common approach. The following quality control parameters were
applied: (i) missing rate per SNP < 0.05 (before sample removal below), (ii) missing rate per
individual < 0.02, (iii) heterozygosity per individual ± _0.2, (iv) missing rate per SNP < 0.02
(after sample removal above), (iv) missing rate per SNP difference in cases and controls <
0.02, (vi) Hardy-Weinberg equilibrium (in controls) P < 10−6, (vii) Hardy-Weinberg
equilibrium (in cases) P < 10−10. Study sample sizes varied between 1,200 and 3,000
individuals. The number of SNPs per study after quality control varied between 420,000 and
640,000. On average, the quality control processes excluded 44 individuals per study (with a
range of 13–107 individuals) and 13,000 SNPs per study (with a range of 3,000–20,000
SNPs). After quality control, the GWAS datasets together comprised 2489 cases and 5287
controls and, for the next steps of the ‘genetic quality control’ analysis, a set of 221,784
SNPs common to all platforms and successfully genotyped in each GWAS sample was
extracted. These SNPs were then further pruned to remove LD (leaving no pairs with r2 >
0.05) and lower frequency SNPs (minor allele frequency < 0.05), leaving 64,099 SNPs
suitable for robust relatedness testing and population structure analysis (see below).
Imputation of untyped SNPs was performed within each study in batches of 300 individuals.
These batches were randomly drawn in order to keep the same case-control ratio as in the
total sample from that study. We used Beagle 3.13. Imputation was performed with CEU
+TSI HapMap phase 3 data (UCSC hg18/NCBI 36) using a chunk size of 10Mb with 410
phased haplotypes comprising 1,233,578 SNPs, using default parameters. Lambda-GC was
carefully monitored before and after imputation.
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Genetic quality control included relatedness testing and principal components analyses
based on 64,099 LD independent SNPs, present on all platforms in this study. Relatedness
testing was done with PLINK,41 reporting pairs with genome identity (pi-hat) > 0.9 as
‘identical samples’ and with pi-hat > 0.2 as being closely related. After random shuffling,
one individual from each related pair was excluded from downstream analysis. From groups
with multiple related pairs (for example, a family), only one individual was kept.
Discovery principal component analysis
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Principal component estimation was done with the same collection of SNPs on the nonrelated subset of individuals. We estimated the first 20 principal components and tested each
of them for phenotype association (using logistic regression with study indicator variables
included as covariates) and evaluated their impact on the genome-wide test statistics using
Lamda-GC (the genomic control inflation factor based on the median Chi-square) after
genome-wide association of the specified principal component. Based on this we decided to
include principal components 1,2,3,4,5,6 for downstream analysis as associated covariates.
Association analysis
The primary scan had a total of 2,332 QC+ cases and 5,233 QC+ controls. Association
testing was carried out in PLINK,41 using the dosage data from the imputation and using the
first six principal components as covariates, chosen as described above from the first 20
principal components. The four datasets had Lamda GC values of 1.025, 1.041, 1.040 and
1.042. A fixed-effect meta-analysis was performed using odds ratios and standard errors.
The final meta-analysis had a Lambda GC of 1.076.
MHC imputation and association analysis

Author Manuscript

Starting from the genotyped SNPs we imputed classical HLA alleles and corresponding
polymorphic amino acids within classical HLA proteins, following a recently described
protocol.8 In total 8,271 variants including SNPs, amino acids and classical HLA alleles at
2- and 4- digit resolution were tested for association in the MHC region. Logistic regression
was applied for testing for association, including the 6 first principal components and a
dummy variable for the cohort id of each sample. Single test association was performed for
all types of variants as well as omnibus tests for the amino acids. The conditional analyses
were performed by using the initial PCA covariates, the dummy variable for cohort, and
adjusting for the top and conditional hits.
Analysis of Immunochip data

Author Manuscript

To identify the sample ethnicities in the case cohort, we calculated the principal components
(PC) 1 and 2 using Hapmap 3, and mapped the case samples to the PCs. Samples that do not
cluster with the Hapmap3 European samples were discarded. The NIDDK control cohort has
been cleaned for sample ethnicity and is thus not necessary to undergo such procedure. For
both case and control cohort, we then removed samples that have missing genotype rate >
2% and variants that have missing genotype rate > 2% for each cohort. For the control
cohort, we additionally removed variants that fail the Hardy Weinberg Equilibrium test (pvalue<1×10−5). The case and the control cohorts were then merged, and we removed
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variants that have different missingness in cases and in controls (p-value<1×10−5) and
samples that have high heterozygosity (>3 standard deviation). We used PLINK to infer the
genetic relationships between the remaining samples and we randomly removed one of the
samples for each related sample pair (PI_HAT>0.5).41 The final cleaned dataset has 318
cases and 1688 controls. We tested the association between the genetic variants and alopecia
areata using PLINK with the principal components 1-5 as covariates.
RT-PCR and immunofluorescence staining on human and mouse tissues

Author Manuscript

RT-PCR was performed on total RNA extracted from plucked human scalp hair follicles
(SHF) and T cells, natural killer cells (NK), B cells, monocytes (MC), peripheral blood
mononuclear cells (PBMCs) that were isolated by FACS from whole blood. The primer
sequences of the BIM, GARP, LNK, and β2M genes are as follows: BIM F: 5’TAAGTTCTGAGTGTGACCGAGA-3’, R: 3’- CCATTGCACTGAGATAGTGGTTG-5’;
GARP F: 5’-CGCTCCCGAGACTCATCTAC-3’, R: 5’AGGTGCTCAAGAAAGCTGTCG-3’; LNK F: 5’-GTGGGGAATACGTGCTCACTT-3’,
R: 5’-TGTCCACGACCGAGGGAAA-3’; β2M F: 5’GAGGCTATCCAGCGTACTCCA-3’, R: 5’- CGGCAGGCATACTCATCTTTT-3’.
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Immunofluorescence staining was performed on human and mouse samples. Human skin
and hair follicle sections were obtained from control occipital scalp biopsies discarded
during surgery and considered to be non-human subject research under 45 CFR Part 46 (IRB
exempted). Mouse anagen skin (day 30), catagen skin (day 42) and telogen skin (day 50)
was harvested from the dorsal region and embedded in Optimal Cutting Temperature
(O.C.T.) for sectioning (10 μm). Slides were fixed with 50% MeOH/50% Acetone for 10
minutes at 220uC, washed with 1X PBS, and then blocked with 2% fish skin gelatin (Sigma
Aldrich, MO, USA). The α-BIM antibody (Rabbit) (Biorbyt, orb10190) was used at a
concentration of 1:200 for both mouse and human studies. Slides were washed, incubated
with the Alexa Fluor 488 donkey anti-rabbit IgG (Molecular Probes, Invitrogen) secondary
antibody (1:800 in 1X PBS), mounted with VECTASHIELD mounting medium with DAPI
(Vector Laboratories, Burlingame, CA, USA), and imaged using a LSM 5 laser-scanning
Axio Observer Z1 confocal microscope (Carl Zeiss).
Cross Phenotype Meta-Analysis
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The protocol for this analysis was adopted from previously described work on cross
phenotype meta-analysis. 43 Using Dataset S1 from the supplementary data section of the
original analysis, we added in AA association p-values for the 107 SNPs originally
investigated. For SNPs with no p-value, we used Broad Institutes SNAP to find a proxy SNP
with r2 > 0.9 (http://www.broadinstitute.org/mpg/snap/). The CPMA statistic was then
recalculated for all 107 SNPs using code (found here: http://coruscant.itmat.upenn.edu/
software.html) implementing the original description. All SNPs meeting a significance
threshold of < 0.01 were included in clustering analysis. Clustering was done by first
binning p-values into four groups based on magnitude and clustered using the cluster
package. Cumulative association statistics were calculated in R using Fisher's omnibus test.
Protein-protein interaction analysis was performed using DAPPLE, a publicly available web
application (http://www.broadinstitute.org/mpg/dapple). Settings for DAPPLE included the
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1000 genome assembly, 5000 permutations, and 50kb regulatory region upstream and
downstream. All statistical analysis was performed in R version 3.0.1.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Manhattan plot for genome-wide tests of association in meta-analysis

In order to conduct a meta-analysis across two GWAS, genotypes were imputed for each
data set yielding 1.2 million SNPs. Standard association analysis with logistic regression
including PC covariates was performed within each cohort and results were combined with
standard-error weighted meta-analysis.
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Figure 2. Positions of amino acid residues demonstrating independent association with alopecia
areata
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Structure of disease associated HLA-DRB1*04*01 allele and polymorphic residues involved
in susceptibility to AA. The peptide binding cleft of an HLA-DR molecule is shown in
cartoon representation with the α-chain colored in blue and β-chain in green. The MHCbound peptide is shown in cartoon representation and colored yellow. Residues His13β and
Tyr37β corresponding to amino acid positions with independent disease association are
shown in stick model along with the shared epitope (residues 70-74). Crystal structure of
HLA DR4 bound to melanocytes lineage-specific antigen gp120 was used (PDB 4IS6).
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Figure 3. Detailed map of associated SNPs and gene locations for newly identified loci

Two regions in the genome exceeded statistical significance when the replication data was
combined with the meta analysis results (N=10,796) and analyzed with logistic regression.
(a). Chromosome 2q13 includes ACOXL and BCL2L11. (b). Chromosome 12q24.12
included C11orf30 and LRCC32 (GARP).
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Figure 4. Characterization BIM, GARP, and LNK expression
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A. BIM, GARP, and LNK expression in human immune cells and hair follicles. RT-PCR was
performed on BIM, GARP, and LNK to determine gene expression in T cells, natural killer
cells (NK), B cells, monocytes (MC), peripheral blood mononuclear cells (PBMCs), and
scalp hair follicles (SHF). 2M PCR was used as a loading control for each cDNA. Two
splice variants are observed for β BIM expression: BIM-S (192 bp) and BIM-L (372 bp).
Expected amplicon sizes: BIM (372 bp and 192 bp), GARP (226 bp), LNK (409 bp). B.
Immunofluorescence staining in human hair follicles reveals that BIM is highly expressed in
matrix cells of the catagen hair bulb. C. In healthy hair follicles from the C67BL6 mouse
strain, BIM is strongly expressed in the apoptosing strand of mouse catagen hair follicles
and is absent from anagen and telogen hair follicles. Immunofluorescence staining on
affected and unaffected skin from the AA mouse model strain, C3H/HeJ, reveals that BIM
expression levels and localization pattern are aberrant in affected hair follicles compared to
unaffected C3H/HeJ and C57BL6 hair follicles.
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Figure 5. Cross Phenotype Meta-Analysis revealing functional clusters of genes and proteins
indicating patterns of shared disease mechanisms across autoimmune diseases

(A). 50 SNPs with evidence of association to more than one autoimmune disease (Pcpma <
0.01) are clustered by association with disease. (B). For each cluster and disease pair, a
cumulative association statistic was calculated using Fisher's omnibus test to combine pvalues. The varying pattern of disease association for each cluster suggests each group
represents a distinct co-morbid mechanism. (C). Proteins coded within a 100 Mb window
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centered on each SNP within each cluster are depicted in protein-protein interaction maps.
Three of the five clusters have significant protein inter-connectivity (permuted P < 0.05).
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Candidate genes in AA GWAS regions.
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Locus

Genes of Interest

SNP

Chr

BP

A1A2

P

OR

6p21.32

HLA-DQB1

rs9275524

6

32,783,087

TC

1.8E-60

0.52

10p15.1

IL15RA,IL2RA

rs3118470

10

6,141,719

TC

7.7E-21

0.71

2q33.2

CD28,CTLA4,ICOS

rs231775

2

204,440,959

AG

2.2E-20

0.72

6q25.1

RAET1L,ULBP3

rs12183587

6

150,396,301

TG

5.9E-24

1.48

11q13

PRDX5

rs574087

11

63,859,524

AG

8.7E-14

1.32

12q13

IKZF4 (Eos),ERBB3

rs2292239

12

54,768,447

TG

4.4E-09

1.25

4q27

IL21,IL2

rs7682481

4

123,743,476

CG

4.8E-09

1.23

5q31.1

IL13,1L4

rs848

5

132,024,399

AC

4.8E-09

1.27

2q13

ACOXL, BCL2L11(BIM)

rs3789129

2

111,414,511

AC

1.5E-08

1.31

11q13.5

GARP(LRRC32)

rs2155219

11

75,976,842

TG

4.1E-08

1.21

1p13.2

PTPN22

rs2476601

1

114,179,091

AG

8.9E-08

1.34

12q24.12

SH2B3(LNK),ATXN2

rs653178

12

110,492,139

TC

1.6E-07

0.84

16p13.13

CIITA,CLEC16A,SOCS1

rs3862469

16

11101581

TC

1.7E-07

0.82

9q31.1

STX17, NR4A3

rs10124366

9

101,727,524

AG

1.1E-05

0.83

Fourteen regions in the genome have demonstrated association with AA by GWAS and replication. For each region, genes of interested are listed,
along with the most significant SNP, its location in the genome, pvalue and OR obtained with logistic regression from the combined analysis
(N=10,796).
P-values and effect estimates from each analytic stage are in Supplementary Table 3.
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